The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic
The western blotting market is projected to reach USD 730.7 million by 2021 from USD 574.8 million in 2016, at a CAGR of 4.9% in the next five years (2016 to 2021).
The western blotting market is undergoing a significant transformation, with the automation of blotting systems and imagers. Furthermore, it is one of the most basic technologies for the separation of proteins and is seen at almost every protein research laboratories. The growth of this market is majorly influenced by the dynamics of the protein research industries.
The increasing number of research activities and R&D spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, growing proteomics market, the growing number of industry-academic research collaborations, increasing demand for personalized medicine, and new product launches are some factors expected to drive the growth of the global western blotting market in the coming years. On the other hand, emergence of alternative technologies is expected to restrain the growth of the market. However, automation in western blotting instruments is expected to pose lucrative opportunities for the western blotting market. Furthermore, stringent regulations and requirement of high procedural efficiency for accurate results are likely to challenge the western blotting market in the coming years.
In 2016, North America is expected to account for the largest share of the global western blotting market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America’s large share is attributed to the increasing prevalence of HIV and Lyme disease, U.S. –China collaborative program for biomedical research, rise in research funding & increasing production of genetically modified crops in the U.S., HIV vaccine initiative, and Growing intensity of pharmaceutical and biopharmaceutical clinical research in Canada. In the coming years, the western blotting market is expected to witness the highest growth in the Asia-Pacific region, with emphasis on India, China, and Japan. This can be attributed to factors such as presence of bioclusters in China and India, outsourcing of research activity in China, increasing government interest in biomedical & biotechnology industry in China, government initiatives supported by funding in Japan, growing pharmaceutical & biotechnology industry in Japan, growing pharmaceutical industry backed by government funding in India, and growing funding for agriculture research in India.
The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (expansions; new product launches; marketing and promotion; agreements, collaborations, partnerships, and joint ventures; funding; acquisitions; and product enhancement to increase their market shares and establish a strong foothold in the global market.
In-depth interviews were conducted with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from various key organizations operating in the adaptive security market place.
- By Company Type: Tier 1: 50%, Tier 2: 35%, Tier 3: 15%
- By Designation: Director Level: 53%, C-Level: 28%, Others: 19%
- By Region: North America: 35%, Europe: 25%, APAC: 28%, ROW: 12%
The report includes the study of key players offering western blotting such as Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), GE Healthcare (U.S.), Advasta, Inc. (U.S.), LI-COR Biosciences (U.S.), PerkinElmer, Inc. (U.S.), Bio-Techne Corporation (U.S.), Merck KGaA (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), and Cell Signaling Technology, Inc. (U.S.).
The report provides a picture on western blotting instruments and consumables across different applications and regions. It aims at estimating the market size and future growth potential of this market across different segments such as product, application, end user, and regions. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market by providing them the closest approximations of the revenue numbers for the overall western blotting market and the subsegments. This report will help stakeholders to better understand the competitor landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. The report also helps the stakeholders to understand the pulse of the market and provides them information on key market drivers, restraints, challenges, and opportunities.